Annual Total Long Term Liabilities
$74.65 M
-$20.45 M-21.50%
December 31, 2024
Summary
- As of March 5, 2025, KYMR annual total long term liabilities is $74.65 million, with the most recent change of -$20.45 million (-21.50%) on December 31, 2024.
- During the last 3 years, KYMR annual total long term liabilities has risen by +$20.92 million (+38.95%).
- KYMR annual total long term liabilities is now -52.31% below its all-time high of $156.54 million, reached on December 31, 2019.
Performance
KYMR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$74.65 M
-$731.00 K-0.97%
December 31, 2024
Summary
- As of March 5, 2025, KYMR quarterly total long term liabilities is $74.65 million, with the most recent change of -$731.00 thousand (-0.97%) on December 31, 2024.
- Over the past year, KYMR quarterly long term liabilities has dropped by -$20.45 million (-21.50%).
- KYMR quarterly long term liabilities is now -52.31% below its all-time high of $156.54 million, reached on December 31, 2019.
Performance
KYMR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KYMR Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.5% | -21.5% |
3 y3 years | +39.0% | -21.5% |
5 y5 years | -52.3% | -21.5% |
KYMR Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -21.5% | +79.3% | -26.0% | +116.6% |
5 y | 5-year | -52.3% | +79.3% | -52.3% | +117.1% |
alltime | all time | -52.3% | +79.3% | -52.3% | +117.1% |
Kymera Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $74.65 M(-21.5%) | $74.65 M(-1.0%) |
Sep 2024 | - | $75.38 M(-4.5%) |
Jun 2024 | - | $78.95 M(-21.8%) |
Mar 2024 | - | $100.91 M(+6.1%) |
Dec 2023 | $95.10 M(+128.4%) | $95.10 M(+1.5%) |
Sep 2023 | - | $93.68 M(+1.9%) |
Jun 2023 | - | $91.92 M(+2.2%) |
Mar 2023 | - | $89.97 M(+116.1%) |
Dec 2022 | $41.64 M | $41.64 M(+20.8%) |
Sep 2022 | - | $34.46 M(-9.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $37.97 M(-17.5%) |
Mar 2022 | - | $46.00 M(-14.4%) |
Dec 2021 | $53.73 M(-42.0%) | $53.73 M(-17.1%) |
Sep 2021 | - | $64.83 M(-4.1%) |
Jun 2021 | - | $67.60 M(-14.6%) |
Mar 2021 | - | $79.17 M(-14.6%) |
Dec 2020 | $92.67 M(-40.8%) | $92.67 M(-12.1%) |
Sep 2020 | - | $105.39 M(+206.5%) |
Jun 2020 | - | $34.39 M(-78.0%) |
Dec 2019 | $156.54 M(+111.6%) | $156.54 M |
Dec 2018 | $73.98 M | - |
FAQ
- What is Kymera Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Kymera Therapeutics?
- What is Kymera Therapeutics annual total long term liabilities year-on-year change?
- What is Kymera Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly long term liabilities year-on-year change?
What is Kymera Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KYMR is $74.65 M
What is the all time high annual total long term liabilities for Kymera Therapeutics?
Kymera Therapeutics all-time high annual total long term liabilities is $156.54 M
What is Kymera Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KYMR annual total long term liabilities has changed by -$20.45 M (-21.50%)
What is Kymera Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KYMR is $74.65 M
What is the all time high quarterly long term liabilities for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly total long term liabilities is $156.54 M
What is Kymera Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KYMR quarterly total long term liabilities has changed by -$20.45 M (-21.50%)